Ben Gurion University researchers have discovered accidentally that alpha1-antitrypsin (AAT) could prevent deadly infections in immune system-compromised patients.  Lethal bacteria in mice were practically eradicated by AAT therapy within 24 hours. http://aabgu.org/anti-inflammatory-drug-may-prevent-deadly-infection/

(Thanks to Israel21c) Intel Israel has developed an advanced analytics platform for researching the symptoms of Parkinson’s disease.  The system can work with smart watches linked to a smartphone and can handle 300 observations per second from each participant. http://www.israel21c.org/headlines/wearable-technology-is-breakthrough-for-parkinsons/ … Continue reading →

Israel’s Teva continues to help keep down US health costs by launching generic versions of two leading antibiotics – Zyvox (linezolid), and Nafcillin – injectable antibiotics for the treatment of severe infections.  Teva also has launched a generic blood-pressure treatment. … Continue reading →

(Thanks to Israel21c) Israel’s Quiet Therapeutics has developed “GAGomers,” a new class of nano-particles (coated with glycosaminoglycan, or GAGs, a polysugar) that specifically target tumors and blood cancers based on a biomarker expressed on malignant tissue. http://www.israel21c.org/headlines/the-nanoparticles-coming-to-attack-cancer/

A breakthrough by researchers at the Hadassah Medical Center in Jerusalem will allow early detection and possible prevention of colon and uterine cancers.  They have discovered a genetic mutation that can identify at-risk patients. http://www.israelhayom.com/site/newsletter_article.php?id=22167

The US FDA and the European Medicines Agency have awarded Israel’s stem cell therapy developer Gamida Cell orphan status for its NiCord leukemia treatment. NiCord treats acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin lymphoma and myelodysplastic syndrome. http://www.globes.co.il/en/article-gamida-cell-leukemia-treatment-granted-orphan-drug-status-1000998856